Jeremy Crew - Concepedia

Author

Jeremy Crew

Also Known As

J Crew, J P Crew, J. Crew, J. P. Crew, J.P. Crew, JEREMY CREW, JEREMY P. CREW, Jeremy Crew, Jeremy P Crew, Jeremy P. Crew

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Churchill Hospital John Radcliffe Hospital University of Oxford Cancer Research UK St James's University Hospital

About

Jeremy Crew is an author at Churchill Hospital specializing in urology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	700
2	Health Sciences	1	1	84
3	Public Health	1	1	16
4	Endocrinology	1	1	16
5	Microbiology	1	1	84

Jeremy Crew

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Vascular Endothelial Growth Factor is a Predictor of Relapse and Stage Progression in Superficial Bladder Cancer Jeremy Crew, Tim O’Brien, Mike Bradburn, The Journal of Urology Vegf ProteinTumor BiologyUrologyAngiogenesisGenitourinary Cancer	1998	226
Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour Nigel C. Cowan, Ben Turney, Nia J. Taylor, British Journal of Urology	2007	200
Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic Christopher Blick, Sarfraz Nazir, Susan Mallett, British Journal of Urology	2011	153
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression Jeremy Crew, S Fuggle, Roy Bicknell, British Journal of Cancer	2000	139
URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATES Jeremy Crew, TIM O'BRIEN, Roy Bicknell, The Journal of Urology	1999	132
Vascular Endothelial Growth Factor is a Predictor of Relapse and Stage Progression in Superficial Bladder Cancer Jeremy Crew, Timothy O’Brien, Mike Bradburn, The Journal of Urology Surgical OncologyPathologyEndothelial Growth FactorReconstructive UrologyUrogenital Radiology	1998	126
The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer Kevin Turner, Jeremy Crew, Charles C. Wykoff, British Journal of Cancer	2002	124
Computed tomography urography for diagnosing bladder cancer Benjamin W. Turney, Jonathan M. Willatt, David E. Nixon, British Journal of Urology	2006	104
Antibiotic resistance - what can we do? Richard Bax, Roy M. Anderson, Jeremy Crew, Nature Medicine Health SciencesAntimicrobial StewardshipAntibioticsMedicineAntimicrobial Therapy	1998	84
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis. Jeremy Braybrooke, Kenneth J. O’Byrne, David Propper, PubMed Chemoprevention StrategyPotential Surrogate MarkersPhase Ii StudyPharmacotherapySurrogate Serum	2000	61

Page 1